MedPath

焦作市民康药业有限公司

Ownership
-
Established
2007-10-31
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:6

Drug Approvals

Magnesium Sulfate Injection

Product Name
硫酸镁注射液
Approval Number
国药准字H20254069
Approval Date
May 13, 2025
NMPA

Potassium Aspartate Injection

Product Name
门冬氨酸钾注射液
Approval Number
国药准字H20244774
Approval Date
Sep 3, 2024
NMPA

Potassium Aspartate Injection

Product Name
门冬氨酸钾注射液
Approval Number
国药准字H20244775
Approval Date
Sep 3, 2024
NMPA

Calcium Gluconate Injection

Product Name
葡萄糖酸钙注射液
Approval Number
国药准字H20163118
Approval Date
Sep 4, 2020
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20093915
Approval Date
Jun 27, 2019
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20094104
Approval Date
Jun 27, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.